Checked.be
Active
BE 0543.727.164Private limited company
ESTEVE PHARMACEUTICALS
Burgemeester Etienne Demunterl. 5 ·1090 Jette, Belgium· 12 yrs active
Sector: Groothandel in farmaceutische en medische artikelen
(46460)
Conclusion
The computed 12-month bankruptcy probability of ESTEVE PHARMACEUTICALS is 1.6% (moderate). The company has been active since 2014 and the Belgian State Gazette contains no insolvency or warning signals. No processed annual-account figures are available; this conclusion rests on registry and State Gazette data only.
Based on State Gazette and CBE data.
Key figures
| Active | 12 yrs |
| Board | 5 |
| Locations | 2 |
| Publications | 21 |
Bankruptcy probability (12 mo)
1.6%
Moderate
0%0,5%1,5%4%10%≥25%
Higher-failure-rate region
+Multiple establishment units
+Higher-failure-rate sector
+
Statistical estimate based on public sources, not credit advice nor a finding of fact. How do we compute this?
Risk Assessment
0 / 100
Low riskTrust signals
Established
Founded in 2014, 12 years in business.
No legal incidents
No bankruptcy, reorganisation or interim measure in the Belgisch Staatsblad, and the KBO register records a normal legal situation.
Administrative Flags
No strikeouts found in the KBO publications we processed. That series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
Financial overview
Financials being processed
NBB has 10 filing(s) on record for this company, latest fiscal year 2024 (volledig). The annual accounts are being processed.
Filings on record
| Fiscal year | Type | Filed | Reference |
|---|---|---|---|
| 31-12-2024 | volledig | 01-07-2025 | 2025-00207484 |
| 31-12-2023 | ander | 25-06-2024 | 2024-00158938 |
| 31-12-2022 | ander | 05-06-2023 | 2023-00105651 |
| 31-12-2021 | ander | 31-08-2022 | 2022-20371901 |
| 31-12-2020 | ander | 03-08-2021 | 2021-45500415 |
| 31-12-2019 | volledig | 23-09-2020 | 2020-54700438 |
| 31-12-2018 | volledig | 02-08-2019 | 2019-42600212 |
| 31-12-2017 | volledig | 24-07-2018 | 2018-36300460 |
| 31-12-2016 | volledig | 14-07-2017 | 2017-30800546 |
| 31-12-2015 | volledig | 08-07-2016 | 2016-29300236 |
Directors & mandates
Current directors & mandates
-
Current14-01-2025 → present
-
Current14-01-2025 → present
-
Current18-01-2023 → present
-
Current30-06-2022 → present
-
Current01-02-2021 → present
Historic, not recently confirmed (3)
These mandates remain open in the register but have not been confirmed by a new act in over six years. They do not count as active directors.
-
Not recently confirmedlast confirmed in an act from 2019
-
Not recently confirmedlast confirmed in an act from 2019
-
Not recently confirmedlast confirmed in an act from 2018
Former directors (10)
-
Former10-07-2024 → 13-01-2025
2 events
- 13-01-2025 Resigned· Director
- 10-07-2024 Appointed· Director
-
Former18-11-2022 → 10-07-2024
2 events
- 10-07-2024 Resigned· Director
- 18-11-2022 Appointed· Director
-
Former- → 10-07-2024
-
Former- → 10-07-2024
-
Former18-11-2022 → 18-01-2023
2 events
- 18-01-2023 Resigned· Director
- 18-11-2022 Appointed· Director
5 further former directors in the mandate history. Available in Kantoor S.
See plans →
Full appointment history from the Belgian State Gazette. Permanent representatives are shown for corporate directors.
Statutory auditor
| Statutory auditor | IRE/IBR number | Tenure |
|---|---|---|
| EY Bedrijfsrevisoren BVCurrent Statutory auditor · represented by Paul Eelen |
- | 22-03-2023 → present |
Show 2 earlier auditors
| KPMG Réviseurs d'Entreprises Statutory auditor · represented by Declercq Olivier succeeded by EY Bedrijfsrevisoren BV in 2023 |
- | 27-07-2021 → 22-03-2023 |
| KPMG Réviseurs d'Entreprises SCRL civile Statutory auditor · represented by Olivier Declercq succeeded by KPMG Réviseurs d'Entreprises in 2021 |
- | 08-10-2015 → 27-07-2021 |
Appointed statutory auditor from the Belgian State Gazette. The IRE/IBR number refers to the register of the Institute of Registered Auditors.
Legal Structure
| NACE primary | Groothandel in farmaceutische en medische artikelen(46460) |
| Legal form | Private limited company(610) |
| Incorporation | 02-01-2014 |
| Status | Active |
| Postal code | 1090 |
Establishment units
Burgemeester Etienne Demunterl. 5/10, 1090 Jette
since 20142.361.969.497
HRA PHARMA BENELUX
since 20142.225.968.866
Physical sites registered in the Crossroads Bank for Enterprises (CBE).
Real-estate footprint
Parcels linked to this company through its CBE addresses (seat, establishment units, branches), cross-referenced with the cadastral parcel plan. This shows where the company operates, not a deeds register.
Flanders
1
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 23015B0091/00S003 | Flanders | 4,582 m² | 1 · 1,166 m² | 22.4 m · 6 fl. |
Methodology
via establishment units: 1
1 of 1 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Updates
A single timeline of everything that happened to this company, publications, insolvency and lifecycle events, administrative changes and filed annual accounts.
2025
20-11-2025
State Gazette act
Director changes
24-07-2025
State Gazette act
Director changes
01-07-2025
NBB filing
Annual accounts filed
04-03-2025
State Gazette act
Statutes amendment
04-02-2025
State Gazette act
Director changes
2024
30-07-2024
State Gazette act
Statutes amendment
26-07-2024
State Gazette act
Director changes
25-06-2024
NBB filing
Annual accounts filed
28-03-2024
State Gazette act
Capital & shares
2023
24-11-2023
State Gazette act
Statutes amendment
05-06-2023
NBB filing
Annual accounts filed
22-03-2023
State Gazette act
Director changes
07-02-2023
State Gazette act
Director changes
2022
06-12-2022
State Gazette act
Director changes
06-12-2022
State Gazette act
Director changes
12-09-2022
State Gazette act
Director changes
31-08-2022
NBB filing
Annual accounts filed
2021
03-08-2021
NBB filing
Annual accounts filed
27-07-2021
State Gazette act
Director changes
02-04-2021
State Gazette act
Director changes
22-03-2021
State Gazette act
Director changes
2020
23-09-2020
NBB filing
Annual accounts filed
2019
02-08-2019
NBB filing
Annual accounts filed
11-07-2019
State Gazette act
Director changes
2018
24-07-2018
NBB filing
Annual accounts filed
11-04-2018
State Gazette act
Director changes
2017
14-07-2017
NBB filing
Annual accounts filed
2016
08-07-2016
NBB filing
Annual accounts filed
2015
08-10-2015
State Gazette act
Director changes
2014
04-11-2014
State Gazette act
Director changes
13-01-2014
State Gazette act
Incorporation
Belgian State Gazette reading coverage
We know of 21 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Belgisch Staatsblad, acts
Capital history · 1
28-03-2024
v3.2
All acts · 21
updated 9 months ago
2025
20-11-2025 Change in the board of directors
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0543.727.164",
"name_full": "ESTEVE PHARMACEUTICALS",
"legal_form": "BV"
}
}24-07-2025 Change in the board of directors
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0543.727.164",
"name_full": "ESTEVE PHARMACEUTICALS",
"legal_form": "BV"
}
}04-03-2025 Articles of association amended
Summary:
v3.2
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2025-02-24",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0543.727.164",
"name_full": "ESTEVE PHARMACEUTICALS",
"legal_form": "BV"
},
"signature_regime": "joint_two",
"special_mandates": [],
"governance_change": {
"admin_delegated_added": []
}
}04-02-2025 2 directors appointed, 1 resigning
- Jacop Tolstrup, Bestuurder
- Ivan Hagay, Bestuurder
- Jorge Muntañola Prat, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jorge Munta\u00F1ola Prat",
"address": null,
"birth_date": null
},
"effective_date": "2025-01-13",
"evidence_quote": "neemt kennis van het ontslag van Jorge Munta\u00F1ola Prat als bestuurder van de Vennootschap zoals aangekondigd aan de Vennootschap met ingang van 23:59 CET op 13 januari 2025"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jacop Tolstrup",
"address": null,
"birth_date": null
},
"effective_date": "2025-01-14",
"evidence_quote": "benoemt Dhr. Jacop Tolstrup en Ivan Hagay als bestuurders van de Vennootschap met ingang van de 14 januari 2025 en voor onbepaalde duur."
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Ivan Hagay",
"address": null,
"birth_date": null
},
"effective_date": "2025-01-14",
"evidence_quote": "benoemt Dhr. Jacop Tolstrup en Ivan Hagay als bestuurders van de Vennootschap met ingang van de 14 januari 2025 en voor onbepaalde duur."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0543.727.164",
"name_full": "ESTEVE PHARMACEUTICALS",
"legal_form": "BV"
}
}2024
30-07-2024 Articles of association amended
Summary:
v3.2
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": true,
"seat_change": false,
"object_change": true,
"effective_date": "2024-07-10",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0543.727.164",
"name_full": "HRA PHARMA BENELUX",
"legal_form": "BV"
},
"signature_regime": "solo",
"special_mandates": [
{
"quote": "De vergadering verleent bijzondere volmacht aan Clifford Chance LLP, handelend via haar kantoor gevestigd te Louizalaan 65, bus 2, 1050 Brussel, daartoe vertegenwoordigd door mevrouw Valerie Pauwels, individueel bevoegd, evenals aan hun bedienden, aangestelden en lasthebbers, met mogelijkheid tot indeplaatsstelling, teneinde de vervulling van de formaliteiten bij een ondernemingsloket met het oog op de inschrijving/aanpassing van de gegevens in de Kruispuntbank van Ondernemingen, en, desgevallend, bij de Administratie van de Belasting over de Toegevoegde Waarde, te verzekeren.",
"holder_kbo": null,
"holder_name": "Clifford Chance LLP",
"scope_categories": [
"KBO",
"filing",
"tax"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}26-07-2024 1 director appointed, 3 resigning
- Jorge Muntañola Prat, Bestuurder
- Mira De Mayer, Bestuurder
- Sonia Hollies, Bestuurder
- Anja van Winsberghe, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Mira De Mayer",
"address": null,
"birth_date": null
},
"effective_date": "2024-07-10",
"evidence_quote": "L\u0027actionnaire acte de la d\u00E9mission de Mira De Mayer, Sonia Hollies et Anja van Winsberghe de leurs fonctions d\u0027administrateur de la Soci\u00E9t\u00E9 avec effet au 10 juillet 2024. Les actionnaires d\u00E9cident de donner d\u00E9charge interm\u00E9diaire aux administrateurs d\u00E9missionnaires dans le cadre de l\u0027accomplissement",
"discharge_granted": false
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Sonia Hollies",
"address": null,
"birth_date": null
},
"effective_date": "2024-07-10",
"evidence_quote": "L\u0027actionnaire acte de la d\u00E9mission de Mira De Mayer, Sonia Hollies et Anja van Winsberghe de leurs fonctions d\u0027administrateur de la Soci\u00E9t\u00E9 avec effet au 10 juillet 2024. Les actionnaires d\u00E9cident de donner d\u00E9charge interm\u00E9diaire aux administrateurs d\u00E9missionnaires dans le cadre de l\u0027accomplissement",
"discharge_granted": false
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Anja van Winsberghe",
"address": null,
"birth_date": null
},
"effective_date": "2024-07-10",
"evidence_quote": "L\u0027actionnaire acte de la d\u00E9mission de Mira De Mayer, Sonia Hollies et Anja van Winsberghe de leurs fonctions d\u0027administrateur de la Soci\u00E9t\u00E9 avec effet au 10 juillet 2024. Les actionnaires d\u00E9cident de donner d\u00E9charge interm\u00E9diaire aux administrateurs d\u00E9missionnaires dans le cadre de l\u0027accomplissement",
"discharge_granted": false
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Jorge Munta\u00F1ola Prat",
"address": null,
"birth_date": null
},
"effective_date": "2024-07-10",
"evidence_quote": "Les actionnaires nomment en tant qu\u0027administrateur unique de la Soci\u00E9t\u00E9, Jorge Munta\u00F1ola Prat, de nationalit\u00E9 espagnole, domicili\u00E9 \u00E0 Crer. Alt De Gironella 36-38 1-1, 08017 Barcelone (Espagne), faisant \u00E9lection de domicile au si\u00E8ge de la Soci\u00E9t\u00E9, avec effet \u00E0 ce jour. Son mandat est pour une dur\u00E9e i"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0543.727.164",
"name_full": "HRA PHARMA BENELUX",
"legal_form": "SRL"
}
}28-03-2024 Transaction in capital or shares
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0543.727.164",
"name_full": "HRA PHARMA BENELUX",
"legal_form": "SRL"
}
}2023
24-11-2023 Articles of association amended
Summary:
v3.2
Technical details
{
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"statute_change": {
"name_change": false,
"seat_change": false,
"object_change": false,
"effective_date": "2023-10-20",
"legal_form_change": false
},
"bedrijfsrevisor": null,
"subject_company": {
"kbo": "0543.727.164",
"name_full": "HRA PHARMA BENELUX",
"legal_form": "SPRL"
},
"signature_regime": "solo",
"special_mandates": [
{
"quote": "7\u00B0 donner tous pouvoirs sp\u00E9ciaux, avec droit de substitution, \u00E0 madame Anouk VAN HECKE, madame Jennifer DE MEYER et madame Nele DESUTTER, faisant \u00E9lection domicile \u00E0 9810 Nazareth, Venecoweg 26, afin de remplir toutes les formalit\u00E9s administratives lesquelles s\u2019imposent en raison de la modification des statuts aupr\u00E8s d\u2019un ou plusieurs guichets d\u2019entreprises agr\u00E9\u00E9s et/ou de l\u2019Administration de la TVA.",
"holder_kbo": null,
"holder_name": "Anouk VAN HECKE",
"scope_categories": [
"administrative_formalities",
"KBO",
"tax"
],
"with_substitution": true
},
{
"quote": "7\u00B0 donner tous pouvoirs sp\u00E9ciaux, avec droit de substitution, \u00E0 madame Anouk VAN HECKE, madame Jennifer DE MEYER et madame Nele DESUTTER, faisant \u00E9lection domicile \u00E0 9810 Nazareth, Venecoweg 26, afin de remplir toutes les formalit\u00E9s administratives lesquelles s\u2019imposent en raison de la modification des statuts aupr\u00E8s d\u2019un ou plusieurs guichets d\u2019entreprises agr\u00E9\u00E9s et/ou de l\u2019Administration de la TVA.",
"holder_kbo": null,
"holder_name": "Jennifer DE MEYER",
"scope_categories": [
"administrative_formalities",
"KBO",
"tax"
],
"with_substitution": true
},
{
"quote": "7\u00B0 donner tous pouvoirs sp\u00E9ciaux, avec droit de substitution, \u00E0 madame Anouk VAN HECKE, madame Jennifer DE MEYER et madame Nele DESUTTER, faisant \u00E9lection domicile \u00E0 9810 Nazareth, Venecoweg 26, afin de remplir toutes les formalit\u00E9s administratives lesquelles s\u2019imposent en raison de la modification des statuts aupr\u00E8s d\u2019un ou plusieurs guichets d\u2019entreprises agr\u00E9\u00E9s et/ou de l\u2019Administration de la TVA.",
"holder_kbo": null,
"holder_name": "Nele DESUTTER",
"scope_categories": [
"administrative_formalities",
"KBO",
"tax"
],
"with_substitution": true
}
],
"governance_change": {
"admin_delegated_added": []
}
}22-03-2023 1 director appointed, 1 resigning
- Paul Eelen, Commissaris
- KPMG bedrijfsrevisoren, Commissaris
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "commissaris_out",
"role": "commissaris",
"person": {
"rrn": null,
"name": "KPMG bedrijfsrevisoren",
"address": null,
"birth_date": null
},
"evidence_quote": "Gezien de vroegtijdige be\u00EBindiging van KPMG bedrijfsrevisoren benoemt de algemene vergadering tot commissaris voor een periode van drie jaar de BV EY Bedrijfsrevisoren (B00160)..."
},
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Paul Eelen",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "BV EY Bedrijfsrevisoren",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "benoemt de algemene vergadering tot commissaris voor een periode van drie jaar de BV EY Bedrijfsrevisoren (B00160), met maatschappelijke zetel te 1831 Diegem, De Kleetlaan 2, die overeenkomstig artikel 3:58 van het Wetboek van Vennootschappen en Verenigingen als vertegenwoordiger aanduidt de vennoot"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0543.727.164",
"name_full": "HRA PHARMA BENELUX",
"legal_form": "BVBA"
}
}07-02-2023 1 director appointed, 1 resigning
- Mira De Maeyer, Bestuurder
- Christophe Van Damme, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Christophe Van Damme",
"address": null,
"birth_date": null
},
"effective_date": "2023-01-18",
"evidence_quote": "Les actionnaires prennent acte de la d\u00E9mission de Christophe Van Damme comme membre du conseil d\u0027administration \u00E0 compter du 18 janvier 2023.",
"discharge_granted": false
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Mira De Maeyer",
"address": null,
"birth_date": null
},
"effective_date": "2023-01-18",
"evidence_quote": "Les actionnaires d\u00E9cident de nommer comme administrateur de la Soci\u00E9t\u00E9 : madame Mira De Maeyer, n\u00E9e le 15/05/1972, domicili\u00E9e \u00E0 Rondebosstraat 80, 1700 Dilbeek, Belgique, avec le num\u00E9ro d\u0027identification 72051535266, \u00E0 partir du 18 janvier 2023."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0543.727.164",
"name_full": "HRA PHARMA BENELUX",
"legal_form": "SPRL"
}
}2022
06-12-2022 2 directors appointed, 2 resigning
- Anja Van Winsberghe, Bestuurder
- Christophe Van Damme, Bestuurder
- Stefan Herpin, Bestuurder
- Martyn Hilton, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Stefan Herpin",
"address": null,
"birth_date": null
},
"effective_date": "2022-11-18",
"evidence_quote": "Les actionnaires d\u00E9cident de d\u00E9missionner Stefan Herpin et Martyn Hilton, comme membres du conseil d\u0027administration \u00E0 compter du 18/11/2022. Les actionnaires remercie M. Stefan Herpin et M. Martyn Hilton pour leurs services rendus.",
"discharge_granted": false
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Martyn Hilton",
"address": null,
"birth_date": null
},
"effective_date": "2022-11-18",
"evidence_quote": "Les actionnaires d\u00E9cident de d\u00E9missionner Stefan Herpin et Martyn Hilton, comme membres du conseil d\u0027administration \u00E0 compter du 18/11/2022. Les actionnaires remercie M. Stefan Herpin et M. Martyn Hilton pour leurs services rendus.",
"discharge_granted": false
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Anja Van Winsberghe",
"address": null,
"birth_date": null
},
"effective_date": "2022-11-18",
"evidence_quote": "Les actionnaires d\u00E9cident de nommer comme administrateur de la Soci\u00E9t\u00E9: - madame Anja Van Winsberghe, [...], \u00E0 partir du 18/11/2022;"
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Christophe Van Damme",
"address": null,
"birth_date": null
},
"effective_date": "2022-11-18",
"evidence_quote": "Les actionnaires d\u00E9cident de nommer comme administrateur de la Soci\u00E9t\u00E9: - madame Anja Van Winsberghe, [...], \u00E0 partir du 18/11/2022; et - monsieur Christophe Van Damme, [...], \u00E0 partir du 18/11/2022."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0543.727.164",
"name_full": "HRA PHARMA BENELUX",
"legal_form": "SPRL"
}
}06-12-2022 Change in the board of directors
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0543.727.164",
"name_full": "HRA PHARMA BENELUX",
"legal_form": "SPRL"
}
}12-09-2022 Sonia Alexis Hollies appointed as director
- Sonia Alexis Hollies, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Sonia Alexis Hollies",
"address": null,
"birth_date": null
},
"effective_date": "2022-06-30",
"evidence_quote": "Les actionnaires d\u00E9cident de nommer Sonia Alexis Hollies, n\u00E9e le 26/10/1969, \u00E0 Guyana, et r\u00E9sidant au 14 Smallbrook CIR Randolph NJ 07869, Etats-Unis, comme membre du conseil d\u0027administration \u00E0 compter du 30 Juin 2022"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0543.727.164",
"name_full": "HRA PHARMA BENELUX",
"legal_form": "SPRL"
}
}2021
27-07-2021 Declercq Olivier reappointed as statutory auditor
- Declercq Olivier, Commissaris
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "commissaris_renew",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Declercq Olivier",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "KPMG R\u00E9viseurs d\u0027Entreprises",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale renomme en tant que commissaire de l\u0027entreprise: KPMG R\u00E9viseurs d\u0027Entreprises (B00001), l\u0027entreprise avec la forme juridique d\u0027un SRL, ayant \u00E9lu domicile a 1930 Zaventem, Luchthaven Brussel Nationaal 1K, qui sera repr\u00E9sent\u00E9e par monsieur Declercq Olivier (IRE Nr. A02076), audite"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0543.727.164",
"name_full": "HRA PHARMA BENELUX",
"legal_form": "SPRL"
}
}02-04-2021 1 director appointed, 1 resigning
- HERPIN, Gérard Stefan, Bestuurder
- Hartley, Alison Patricia, Bestuurder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Hartley, Alison Patricia",
"address": null,
"birth_date": null
},
"effective_date": "2021-02-01",
"evidence_quote": "L\u0027assembl\u00E9e constate la d\u00E9mission en tant qu\u0027administrateur de la soci\u00E9t\u00E9 \u00E0 dater d\u0027aujourd\u0027hui de Madame Patricia, Alison Hartley. L\u0027assembl\u00E9e remercie l\u0027administrateur d\u00E9missionnaire pour la mani\u00E8re dont elle a exerc\u00E9 son mandat et pour la contribution apport\u00E9 au d\u00E9veloppement de la soci\u00E9t\u00E9.",
"discharge_granted": true
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "HERPIN, G\u00E9rard Stefan",
"address": null,
"birth_date": null
},
"effective_date": "2021-02-01",
"evidence_quote": "Ensuite, l\u0027assembl\u00E9e d\u00E9cide, \u00E0 l\u0027unanimit\u00E9 des voix, de proc\u00E9der \u00E0 la nomination d\u0027un nouveaux administrateur et nomme en cette qualit\u00E9, \u00E0 l\u0027unanimit\u00E9 des voix, pour une p\u00E9riode ind\u00E9termin\u00E9e, commen\u00E7ant ce jour : -Monsieur Stefan, G\u00E9rard HERPIN, demeurant \u00E0 14 rue Pierre et Marie Curie, F-75005 PARI"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0543.727.164",
"name_full": "HRA PHARMA BENELUX",
"legal_form": "SPRL"
}
}22-03-2021 Change in the board of directors
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0543.727.164",
"name_full": "HRA PHARMA BENELUX",
"legal_form": "SPRL"
}
}2019
11-07-2019 2 directors appointed, 2 resigning
- Martyn, Stuart Hilton, Zaakvoerder
- Patricia, Allson Hartley, Zaakvoerder
- David Wright, Zaakvoerder
- Luc Massart, Zaakvoerder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "David Wright",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "Laboratoire HRA PHARMA",
"address": null,
"country": null,
"legal_form": null
},
"effective_date": "2019-04-01",
"evidence_quote": "L\u0027assembl\u00E9e constate les d\u00E9missions en tant que g\u00E9rants de la soci\u00E9t\u00E9 \u00E0 dater d\u0027aujourd\u0027hui de Monsieur Luc Massart et de la soci\u00E9t\u00E9 Laboratoire HRA PHARMA, ici repr\u00E9sent\u00E9e par Monsieur David Wright.",
"discharge_granted": false
},
{
"kind": "director_out",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Luc Massart",
"address": null,
"birth_date": null
},
"effective_date": "2019-04-01",
"evidence_quote": "L\u0027assembl\u00E9e constate les d\u00E9missions en tant que g\u00E9rants de la soci\u00E9t\u00E9 \u00E0 dater d\u0027aujourd\u0027hui de Monsieur Luc Massart et de la soci\u00E9t\u00E9 Laboratoire HRA PHARMA, ici repr\u00E9sent\u00E9e par Monsieur David Wright.",
"discharge_granted": false
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Martyn, Stuart Hilton",
"address": null,
"birth_date": null
},
"effective_date": "2019-04-01",
"evidence_quote": "Ensuite, l\u0027assembl\u00E9e d\u00E9cide, \u00E0 l\u0027unanimit\u00E9 des voix, de proc\u00E9der \u00E0 la nomination de nouveaux g\u00E9rants et nomme en cette qualit\u00E9, \u00E0 l\u0027urianimit\u00E9 des voix, pour une p\u00E9riode ind\u00E9termin\u00E9e, commen\u00E7ant ce jour : -Monsieur Martyn, Stuart Hilton, demeurant \u00E0 40 All\u00E9e des Sablons, La Celle St Cloud (F-78170)"
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "Patricia, Allson Hartley",
"address": null,
"birth_date": null
},
"effective_date": "2019-04-01",
"evidence_quote": "Ensuite, l\u0027assembl\u00E9e d\u00E9cide, \u00E0 l\u0027unanimit\u00E9 des voix, de proc\u00E9der \u00E0 la nomination de nouveaux g\u00E9rants et nomme en cette qualit\u00E9, \u00E0 l\u0027urianimit\u00E9 des voix, pour une p\u00E9riode ind\u00E9termin\u00E9e, commen\u00E7ant ce jour : -Madame Patricia, Allson Hartley, demeurant \u00E0 Chemin du Bois, Ablis (F-78660)"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0543.727.164",
"name_full": "HRA PHARMA BENELUX",
"legal_form": "SPRL"
}
}2018
11-04-2018 2 directors appointed
- KPMG Réviseurs d'Entreprises SCRL civile, Commissaris
- MASSART Luc Adrien Georges, Zaakvoerder
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "KPMG R\u00E9viseurs d\u0027Entreprises SCRL civile",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire du 4 juillet 2017 a d\u00E9cid\u00E9 \u00E9galement \u00E0 l\u0027unan\u00EDmit\u00E9 des voix que KPMG R\u00E9viseurs d\u0027Entreprises SCRL civile (B00001), avenue du Bourget 40 \u00E0 1130 Bruxelles, est nomm\u00E9 en tant que commissaire pour un mandat d\u0027une dur\u00E9e de trois ans."
},
{
"kind": "director_in",
"role": "zaakvoerder",
"person": {
"rrn": null,
"name": "MASSART Luc Adrien Georges",
"address": null,
"birth_date": null
},
"evidence_quote": "L\u0027assembl\u00E9e d\u00E9cide \u00E9galement \u00E0 l\u0027unanimit\u00E9 des voix de nommer en tant que g\u00E9rant non statutaire suppl\u00E9mentaire, Monsieur MASSART Luc Adrien Georges (carte nationale d\u0027identit\u00E9 n\u00B0 100275J00359), n\u00E9 \u00E0 Paris 16i\u00E8me (France) le quatre d\u00E9cembre mille neuf cent cinquante-huit, demeurant \u00E0 Pans 9i\u00E8me (Fran"
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0543.727.164",
"name_full": "HRA PHARMA BENELUX",
"legal_form": "SPRL"
}
}2015
08-10-2015 Olivier Declercq appointed as statutory auditor
- Olivier Declercq, Commissaris
Summary:
v3.2
Technical details
{
"events": [
{
"kind": "commissaris_in",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Olivier Declercq",
"address": null,
"birth_date": null
},
"via_org": {
"kbo": null,
"name": "KPMG R\u00E9viseurs d\u0027Entreprises SCRL civile",
"address": null,
"country": null,
"legal_form": null
},
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale ordinaire du 30 juin 2015 a d\u00E9cid\u00E9 \u00E9galement \u00E0 l\u0027unanimit\u00E9 des voix que KPMG R\u00E9viseurs d\u0027Entreprises SCRL civile (B00001), avenue du Bourget \u00E0 1130 Bruxelles, est nomm\u00E9 en tant que commissaire pour un mandat d\u0027une dur\u00E9e de trois ans."
}
],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0543.727.164",
"name_full": "HRA PHARMA BENELUX",
"legal_form": "SPRL"
}
}2014
04-11-2014 Change in the board of directors
Summary:
v3.2
Technical details
{
"events": [],
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"subject_company": {
"kbo": "0543.727.164",
"name_full": "HRA PHARMA BENELUX",
"legal_form": "SPRL"
}
}13-01-2014 Incorporation of a new SRL
Summary:
oprichting
Technical details
{
"kind": "oprichting",
"seat": "Avenue Bourgmestre Etienne Demunter 5 bo\u00EEte 10 \u00E0 1090 Jette",
"schema": "v3.2",
"act_meta": {
"model_id": 36,
"extractor": "constrained-core-35b"
},
"founders": [
{
"org": {
"kbo": null,
"name": "LABORATOIRE HRA PHARMA"
},
"kind": "rechtspersoon",
"person": null,
"share_class": "A",
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": "LABORATOIRE HRA PHARMA",
"contribution_type": "cash",
"amount_paid_in_eur": 18550,
"holder_person_name": null,
"is_subscriber_only": true,
"n_shares_subscribed": 1855,
"amount_subscribed_eur": 18550,
"is_anonymous_silent_partner": false
},
{
"org": {
"kbo": null,
"name": "HRA PHARMA France"
},
"kind": "rechtspersoon",
"person": null,
"share_class": null,
"partner_role": null,
"holder_org_kbo": null,
"holder_org_name": "HRA PHARMA France",
"contribution_type": null,
"amount_paid_in_eur": 0,
"holder_person_name": null,
"is_subscriber_only": false,
"n_shares_subscribed": 0,
"amount_subscribed_eur": 0,
"is_anonymous_silent_partner": false
}
],
"capital_eur": 18550,
"subject_company": {
"kbo": "0543.727.164",
"name_full": "HRA PHARMA BENELUX",
"legal_form": "SRL"
},
"initial_directors": [],
"incorporation_date": "2013-12-31",
"post_incorporation_mandates": []
}Credit advice
Company registry (CBE)
Activities
Groothandel in farmaceutische en medische artikelen46460Handelsbemiddeling in de groothandel in meubelen, huishoudelijke artikelen en ijzerwaren46150
Primary activity highlighted.
Names & trade names
| Legal nameNL | ESTEVE PHARMACEUTICALS |
Registered office
Burgemeester Etienne Demunterl. 5 bus 10
1090 Jette, Belgium
Official data from the Crossroads Bank for Enterprises (CBE). Available for every registered company.
Similar companies
AUROBINDO
BE 0739.963.411 · Jette
BREVANNES PEDI - CENTER
BE 0451.745.430 · Jette
MEDICAL AND PHARMACEUTICAL SERVICES AND SUPPLIES
BE 0771.869.283 · Jette
Medtronic Belgium
BE 0415.262.839 · Jette
NEWCLIP TECHNICS BELGIUM
BE 0786.739.680 · Jette